We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 41-60 of 10,000 results
  1. Efficacy and Safety of Ivabradine in Combination with Beta-Blockers in Patients with Stable Angina Pectoris: A Systematic Review and Meta-analysis

    Introduction

    Beta-blockers are recommended by the European Society of Cardiology as first-line antianginal therapy for reducing heart rate (HR) and...

    Alexander Nedoshivin, Parvoleta T. S. Petrova, Yuri Karpov in Advances in Therapy
    Article Open access 17 July 2022
  2. Pre-operative beta-blocker therapy does not affect short-term mortality after esophageal resection for cancer

    Background

    It has been postulated that the hyperadrenergic state caused by surgical trauma is associated with worse outcomes and that β-blockade may...

    Souheil Reda, Rebecka Ahl, ... Shahin Mohseni in BMC Surgery
    Article Open access 22 December 2020
  3. Long-acting antimuscarinic therapy in patients with chronic obstructive pulmonary disease receiving beta-blockers

    Background

    Beta-blocker therapies for cardiovascular comorbidities are often withheld in patients with chronic obstructive pulmonary disease (COPD)...

    Kenneth R. Chapman, Robert A. Wise, ... Esther Garcia Gil in Respiratory Research
    Article Open access 22 October 2021
  4. Adjudin improves beta cell maturation, hepatic glucose uptake and glucose homeostasis

    Aims/hypothesis

    Recovering functional beta cell mass is a promising approach for future diabetes therapies. The aim of the present study is to...

    Lipeng Ren, Jérémie Charbord, ... Olov Andersson in Diabetologia
    Article Open access 16 October 2023
  5. SERCA2 regulates proinsulin processing and processing enzyme maturation in pancreatic beta cells

    Aims/hypothesis

    Increased circulating levels of incompletely processed insulin (i.e. proinsulin) are observed clinically in type 1 and type 2...

    Hitoshi Iida, Tatsuyoshi Kono, ... Carmella Evans-Molina in Diabetologia
    Article Open access 04 August 2023
  6. Beta-blockers and mechanical dyssynchrony in heart failure assessed by radionuclide ventriculography

    Background

    Radionuclide ventriculography (RNVG) can be used to quantify mechanical dyssynchrony and may be a valuable adjunct in the assessment of...

    K. A. Jones, C. A. Paterson, ... N. E. R. Goodfield in Journal of Nuclear Cardiology
    Article Open access 23 November 2022
  7. Beta blocker use in traumatic brain injury based on the high-sensitive troponin status (BBTBBT): methodology and protocol implementation of a double-blind randomized controlled clinical trial

    Background

    Beta-adrenergic receptor blockers (BB) play an important role in the protection of organs that are susceptible for secondary injury due to...

    Ayman El-Menyar, Mohammad Asim, ... Hassan Al-Thani in Trials
    Article Open access 07 December 2021
  8. Beta-blockade is not associated with improved outcomes in isolated severe extracranial injury: an observational cohort study

    Background

    There is evidence supporting the use of beta-blockade in patients with traumatic brain injury. The reduction in sympathetic drive is...

    Lin Sadi, Gabriel Sjölin, Rebecka Ahl Hulme in Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
    Article Open access 08 September 2021
  9. Anesthetic implications and role of preoperative beta blockade in esophageal substitution with stomach in pediatric surgical patients

    Background

    There is a paucity of literature on the anesthetic management of pediatric esophageal substitution using the stomach. We did a...

    Raksha Kundal, Ranju Singh, ... Vijay Kumar Kundal in Ain-Shams Journal of Anesthesiology
    Article Open access 28 September 2021
  10. Beta-blockade in V-V ECMO

    Aravind K. Bommiasamy, Bishoy Zakhary, Ran Ran in Critical Care
    Article Open access 25 April 2024
  11. Combination therapy of beta-blockers and digoxin is associated with increased risk of major adverse cardiovascular events and all-cause mortality in patients with atrial fibrillation: a report from the GLORIA–AF registry

    The effect of digoxin and beta-blockers on cardiovascular outcomes and mortality remains unclear. The study aimed to determine differences in...

    Steven Ho Man Lam, Giulio Francesco Romiti, ... Gregory Yoke Hong Lip in Internal and Emergency Medicine
    Article Open access 23 May 2024
  12. Higher systolic blood pressure is specifically associated with better islet beta-cell function in T2DM patients with high glycemic level

    Background

    Patients with type 2 diabetes mellitus (T2DM) usually have higher blood viscosity attributed to high blood glucose that can decrease blood...

    Zhang **a, Lijuan Song, ... Yan He in Cardiovascular Diabetology
    Article Open access 19 December 2022
  13. Association Between Beta-Blockers and Mortality and Readmission in Older Patients with Heart Failure: an Instrumental Variable Analysis

    Background

    The demographics of heart failure are changing. The rate of growth of the “older” heart failure population, specifically those ≥ 75, has...

    Lauren Gilstrap, Andrea M. Austin, ... Jonathan Skinner in Journal of General Internal Medicine
    Article 07 June 2021
  14. Compromised trigemino-coerulean coupling in migraine sensitization can be prevented by blocking beta-receptors in the locus coeruleus

    Background

    Migraine is a disabling neurological disorder, characterized by recurrent headaches. During migraine attacks, individuals often experience...

    Jérémy Signoret-Genest, Maxime Barnet, ... Lénaïc Monconduit in The Journal of Headache and Pain
    Article Open access 08 December 2023
  15. Hypotension and respiratory events related to electrical cardioversion for atrial fibrillation or atrial flutter in the emergency department

    Introduction

    Electrical cardioversion for atrial fibrillation/atrial flutter (AF/AFL) is common in the ED. Our previous work showed that hypotension...

    Sharon Liu, Ian Stiell, ... Keerat Grewal in Canadian Journal of Emergency Medicine
    Article 25 November 2023
  16. Use of Non-selective Beta blockers in Decompensated Cirrhosis and ACLF

    Purpose of Review

    Our understanding of beta blockers in liver cirrhosis has transformed over the last 40 years. However, questions remain over their...

    Kohilan Gananandan, Raj Mookerjee, Rajiv Jalan in Current Hepatology Reports
    Article Open access 09 June 2022
  17. The Role of Systemic and Topical Beta-Blockers in Dermatology: A Systematic Review

    Introduction

    Beta-blockers are proven to be safe and cost-effective agents in treating multiple dermatological conditions, which is why they are...

    Alya M. Alhazmi, Mohammad A. Basendwh, ... Turki S. Aljuhani in Dermatology and Therapy
    Article Open access 22 November 2022
Did you find what you were looking for? Share feedback.